|
|
Volumn 5, Issue 9, 2000, Pages 640-647
|
|
Cost-effectiveness of management strategies for acute urethritis in the developing world
|
|
Author keywords
Cost effectiveness; Syndromic approach; Treatment; Urethritis
|
|
Indexed keywords
ANTIBIOTIC AGENT;
CEFIXIME;
COTRIMOXAZOLE;
DOXYCYCLINE;
KANAMYCIN;
DISEASE CONTROL;
DISEASE TREATMENT;
DRUG PRESCRIBING;
ARTICLE;
COST EFFECTIVENESS ANALYSIS;
DOSE RESPONSE;
DRUG COST;
GONOCOCCAL URETHRITIS;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MODEL;
NONSPECIFIC URETHRITIS;
WORLD HEALTH ORGANIZATION;
ACUTE DISEASE;
ANTI-BACTERIAL AGENTS;
ANTI-INFECTIVE AGENTS;
CEFIXIME;
COST-BENEFIT ANALYSIS;
DECISION TREES;
DEVELOPING COUNTRIES;
DOXYCYCLINE;
DRUG COSTS;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
GONORRHEA;
HUMANS;
KANAMYCIN;
MALE;
SENSITIVITY AND SPECIFICITY;
SYNDROME;
TREATMENT OUTCOME;
TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;
URETHRITIS;
|
|
EID: 0033772934
PISSN: 13602276
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-3156.2000.00616.x Document Type: Article |
|
Times cited : (6)
|
|
References (20)
|
